2024 ICD-10-CM Diagnosis Code D61.02

by

Shwachman-Diamond syndrome

  • D61.02 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • ICD-10-CM D61.02 is a new 2024 ICD-10-CM code that became effective on October 1, 2023.
  • This is the American ICD-10-CM version of D61.02 – other international versions of ICD-10 D61.02 may differ.

Use Additional

  • code, if applicable, for genetic susceptibility to other malignant neoplasm (Z15.09)

Code Also

  • , if applicable, associated conditions such as:
  • acute myeloblastic leukemia (C92.0-)
  • exocrine pancreatic insufficiency (K86.81)
  • myelodysplastic syndrome (D46.-)

The following code(s) above D61.02 contain annotation back-references

 that may be applicable to D61.02:

  • D50-D89  Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
  • D61  Other aplastic anemias and other bone marrow failure syndromes

ICD-10-CM D61.02 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 808 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with mcc
  • 809 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with cc
  • 810 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders without cc/mcc

Code History

  • 2024 (effective 10/1/2023): New code

Diagnosis Index entries containing back-references to D61.02:

  • Syndrome – see also Disease
    • Schwachman D61.02 (-Diamond)
    • Shwachman D61.02 (-Diamond)